Cancer Gene Therapy, Published online: 01 October 2026; doi:10.1038/s41417-026-01086-9 METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells
Huan Liu, ZhongCong Guo, Lan Li, YuXuan Dong, Nian Chen, ZhengTai Yuan. METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells. // Cancer Gene Therapy. – 2026. – DOI: 10.1038/s41417-026-01086-9. – URL: https://www.nature.com/articles/s41417-026-01086-9
Huan Liu, ZhongCong Guo, Lan Li, YuXuan Dong, Nian Chen, & ZhengTai Yuan (2026). METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells. Cancer Gene Therapy. https://doi.org/10.1038/s41417-026-01086-9
Huan Liu, et al. “METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells.” Cancer Gene Therapy, 2026. doi:10.1038/s41417-026-01086-9.
@article{Liu2026,
title = {METTL3-mediated m⁶A methylation of E2F2 targets MCU to promote the malignant phenotype of gastric cancer cells},
author = {Liu, Huan and Guo, ZhongCong and Li, Lan and Dong, YuXuan and Chen, Nian and Yuan, ZhengTai},
journal = {Cancer Gene Therapy},
year = {2026},
doi = {10.1038/s41417-026-01086-9},
url = {https://www.nature.com/articles/s41417-026-01086-9}
}